GEG
Great Elm Group, Inc.
NASDAQ · Healthcare · Medical - Distribution · US
$2.22
+0.91%Year over year
Reported trailing growth
- Revenue
- +70.2%
- EBITDA
- —
- EBIT
- -75.1%
- EPS
- —
- Free cash flow
- +309.8%
- Operating cash flow
- +309.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +47.5%
- EBITDA
- —
- EBIT
- -75.1%
- Net income
- —
- EPS
- —
- Free cash flow
- +231.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026